This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of severe hyperkalaemia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek expert advice.

Severe hyperkalaemia has been defined in this context as plasma potassium of ≥6.5 mmol/L

  • it is considered as a life threatening condition due to its serious cardiac and neuromuscular effects (e.g. - cardiac arrest and paralysis of the respiratory muscles)
  • urgent treatment is warranted in the following patients
    • serum potassium concentration of greater than 6.5 mmol/l regardless of ECG changes
    • serum potassium concentration of greater than 6.0 mmol/l with ECG changes
  • pre-emptive treatment is also recommended in the following patients:
    • rapid rise of serum potassium
    • the presence of significant acidosis
    • rapid deterioration in renal function (1)

Management of severe hyperkalaemic patient involves the following steps:

  • clinically assess the patient
  • check that the potassium level is not an artifact e.g. that the sample was not haemolysed
  • stop any infusions containing potassium or drugs causing potassium retention
  • obtain an ECG and place on constant monitoring
  • immediate treatment principals include:
  • protect the heart - to reduce arrhythmias
    • calcium chloride, 10 mL of 10% solution IV over 5 to 10 minutes, or calcium gluconate, 30 mL of 10% solution IV over 5 to 10 minutes
      • has no effect on plasma potassium concentration
      • beneficial ECG changes can be seen after 1-3 minutes of administration and the effect can last for 30-60 minutes
      • dose could be repeated if follow up ECG after 5 minitues continues to show signs of hyperkalaemia
      • calcium is known to potentiate cardiac toxicity of digoxin, hence caution should be exercised in administering calcium to patients taking digoxin
  • shift potassium into cells
    • insulin-glucose (10 units soluble insulin in 25g glucose) by intravenous infusion
      • hypokalaemic effect of this treatment can be seen within 20 minutes, peaking between 30 and 60 minutes, and it may last for 6 hours
      • effect is temporary and hence requires a slow continuous infusion and frequent capillary blood glucose (CBG) monitoring
    • nebulised salbutamol -
      • at a dose of 10-20 mg diluted in 4 ml of normal saline, given through a nebuliser
      • effect may be seen in 30 minutes, with maximum effect at 90–120 minutes.
      • can be used alone or to augment the effect of insulin
        • UK Kidney Association recommends that salbutamol should not be used as monotherapy in the treatment of severe hyperkalaemia
    • intravenous sodium bicarbonate (500 ml of a 1.26% solution [75 mmol] over 60 minutes)
      • although often used for treatment, its benefit is uncertain and routine use for treatment of hyperkalaemia remains controversial
  • remove potassium from the body
    • cation-exchange resins are not used in the emergency treatment of severe hyperkalaemia (1,2)
    • patiromer
      • NICE suggests that (3):
        • patiromer is recommended as an option for treating hyperkalaemia in adults in emergency care for acute life-threatening hyperkalaemia alongside standard care
        • noted that patiromer would not replace intravenous insulin and glucose, but it might replace calcium resonium

Once the patient is stabilised:

  • avoid potassium sparing or retaining drugs e.g. potassium sparing diuretics (e.g. frumil), beta-blockers, ACE inhibitors, NSAIDS, aspirin
  • a low potassium diet

Notes (1):

  • the threshold for emergency treatment varies, but most guidelines recommend that emergency treatment should be given if the serum K+ is >= 6.5 mmol/L with or without ECG changes


(1) Nyirenda MJ et al. Hyperkalaemia. BMJ. 2009;339:b4114.

(2) UK Kidney Association. Clinical Practice Guidelines - Management of Hyperkalaemia in Adults. October 2023.

(3) NICE (February 2020). Patiromer for treating hyperkalaemia

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.